Literature DB >> 17853434

The number of dopaminergic cells is increased in the olfactory bulb of monkeys chronically exposed to MPTP.

Silvia Belzunegui1, Waldy San Sebastián, Pablo Garrido-Gil, Amaya Izal-Azcárate, Marianne Vázquez-Claverie, Berta López, Irene Marcilla, José Luis Lanciego, Maria Rosario Luquin.   

Abstract

We investigated the impact of the nigrostriatal lesion on the olfactory tyrosine hydroxylase-immunoreactive (TH-ir) cells in monkeys. The majority of these TH-ir cells appeared in the glomerular layer of the olfactory bulb and many were immature but functional dopaminergic neurons. In parkinsonian monkeys the number of olfactory dopaminergic neurons increased up to 100% as compared to controls, but their phenotype did not change. This increased TH-ir cell population might be a direct consequence of the nigral cell loss and contribute to the hyposmia reported by Parkinson's disease patients. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17853434     DOI: 10.1002/syn.20451

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  12 in total

Review 1.  The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.

Authors:  D J Surmeier; J N Guzman; J Sanchez-Padilla; P T Schumacker
Journal:  Neuroscience       Date:  2011-08-25       Impact factor: 3.590

2.  Sall3 correlates with the expression of TH in mouse olfactory bulb.

Authors:  Xin Heng; Heinz Breer; Xin Zhang; Yu Tang; Jia Li; Sufang Zhang; Weidong Le
Journal:  J Mol Neurosci       Date:  2011-06-24       Impact factor: 3.444

Review 3.  Olfaction in Parkinson's disease and related disorders.

Authors:  Richard L Doty
Journal:  Neurobiol Dis       Date:  2011-12-20       Impact factor: 5.996

Review 4.  Physiological phenotype and vulnerability in Parkinson's disease.

Authors:  D James Surmeier; Jaime N Guzman; Javier Sanchez; Paul T Schumacker
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

5.  Trehalose ameliorates prodromal non-motor deficits and aberrant protein accumulation in a rotenone-induced mouse model of Parkinson's disease.

Authors:  Soung Hee Moon; Young Eun Huh; Hyun Jin Choi; Yoonjung Kwon
Journal:  Arch Pharm Res       Date:  2022-05-26       Impact factor: 6.010

Review 6.  Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-08-31       Impact factor: 3.575

Review 7.  Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease.

Authors:  D James Surmeier; Jaime N Guzman; Javier Sanchez-Padilla
Journal:  Cell Calcium       Date:  2010-01-06       Impact factor: 6.817

Review 8.  Olfactory dysfunction in Parkinson disease.

Authors:  Richard L Doty
Journal:  Nat Rev Neurol       Date:  2012-05-15       Impact factor: 42.937

Review 9.  Calcium homeostasis, selective vulnerability and Parkinson's disease.

Authors:  C Savio Chan; Tracy S Gertler; D James Surmeier
Journal:  Trends Neurosci       Date:  2009-03-21       Impact factor: 13.837

Review 10.  The role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelism.

Authors:  Hemant Kumar; Hyung-Woo Lim; Sandeep Vasant More; Byung-Wook Kim; Sushruta Koppula; In Su Kim; Dong-Kug Choi
Journal:  Int J Mol Sci       Date:  2012-08-21       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.